|
|
|
|
Vol. 57, Issue 3, 474-484, March 2000
-Aminobutyric Acid Type A Receptor
2 Subunit Affects Allosteric Sensitivity to GABA and
Anesthetics
Department of Pharmacology, The Royal Danish School of Pharmacy,
Copenhagen, Denmark (B.X.C., A.C.E., U.K., A.S.); and Department of
Molecular and Medical Pharmacology, UCLA School of Medicine, Los
Angeles, California (R.W.O)
Site-directed mutagenesis of the
-aminobutyric acid type A
(GABAA) receptor
2 subunit has demonstrated
that conversion of a conserved glycine residue located at the entrance
to the first transmembrane domain into the homologous
1
residue phenylalanine alters the modulating effects of four different
i.v. anesthetics: pentobarbital, alphaxalone, etomidate, and propofol.
Using the baculovirus expression system in Spodoptera
frugiperda 9 cells, anesthetic-induced enhancement of
[3H]muscimol and [3H]flunitrazepam binding
in receptors containing the
2(G219F) point mutation
displayed a significantly reduced efficacy in modulation by all four
i.v. anesthetics tested. Furthermore, GABAA receptors containing the
1(G223F) point mutation also
significantly decreased the maximal effect of etomidate- and
propofol-induced enhancement of ligand binding. Conversely, the
homologous point mutation in
1 receptors (F261G) changed
the i.v. anesthetic-insensitive receptor to confer anesthetic
modulation of [3H]muscimol binding. Consistent with the
binding, functional analysis of pentobarbital-enhanced GABA currents
recorded with whole-cell patch clamp demonstrated the
2(G219F) subunit mutation eliminated the potentiating
effect of the anesthetic. Similarly, propofol-enhanced GABA currents
were potentiated less in
1
2(G219F)
2 receptors than
in
1
2
2 receptors. Although
ligand binding displayed comparable KD values for muscimol
among wild-type,
1
2
2, and
mutant receptors, patch-clamp recordings showed that
1
2(G219F)
2 receptors had a
significantly more potent response to GABA than did
1
2
2 or
1(G223F)
2
2. The
1
2(G219F)
2 receptors also
were more sensitive to direct channel activation by pentobarbital and
propofol in the absence of GABA. These results suggest that the first
transmembrane glycine residue on the
2 subunit may be
important for conformational or allosteric interactions of channel
gating by both GABA and anesthetics.
This article has been cited by other articles:
![]() |
X.-Q. Hu and R. W. Peoples Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Drafts and J. L. Fisher Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1094 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ernst, S. Bruckner, S. Boresch, and W. Sieghart Comparative Models of GABAA Receptor Extracellular and Transmembrane Domains: Important Insights in Pharmacology and Function Mol. Pharmacol., November 1, 2005; 68(5): 1291 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Jones-Davis, L. Song, M. J. Gallagher, and R. L. Macdonald Structural Determinants of Benzodiazepine Allosteric Regulation of GABAA Receptor Currents J. Neurosci., August 31, 2005; 25(35): 8056 - 8065. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Feng and R. L. Macdonald Multiple Actions of Propofol on {alpha}{beta}{gamma} and {alpha}{beta}{delta} GABAA Receptors Mol. Pharmacol., December 1, 2004; 66(6): 1517 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Smith, B. Oxley, S. Malpas, G. V. Pillai, and P. B. Simpson Compounds Exhibiting Selective Efficacy for Different {beta} Subunits of Human Recombinant {gamma}-Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 601 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Salmi, K. K. Kaisti, L. Metsahonkala, V. Oikonen, S. Aalto, K. Nagren, S. Hinkka, J. Hietala, E. R. Korpi, and H. Scheinin Sevoflurane and Propofol Increase 11C-Flumazenil Binding to Gamma-Aminobutyric AcidA Receptors in Humans Anesth. Analg., November 1, 2004; 99(5): 1420 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Streiff, N. O. Juranic, S. I. Macura, D. O. Warner, K. A. Jones, and W. J. Perkins Saturation Transfer Difference Nuclear Magnetic Resonance Spectroscopy As a Method for Screening Proteins for Anesthetic Binding Mol. Pharmacol., October 1, 2004; 66(4): 929 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rusch, H. Zhong, and S. A. Forman Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-s. S. Chang, R. Olcese, and R. W. Olsen A Single M1 Residue in the {beta}2 Subunit Alters Channel Gating of GABAA Receptor in Anesthetic Modulation and Direct Activation J. Biol. Chem., October 31, 2003; 278(44): 42821 - 42828. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Engblom, B. X. Carlson, R. W. Olsen, A. Schousboe, and U. Kristiansen Point Mutation in the First Transmembrane Region of the beta 2 Subunit of the gamma -Aminobutyric Acid Type A Receptor Alters Desensitization Kinetics of gamma -Aminobutyric Acid- and Anesthetic-induced Channel Gating J. Biol. Chem., May 10, 2002; 277(20): 17438 - 17447. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maruoka, Y. Nagasoe, S. Inoue, Y. Mori, J. Goto, M. Ikeda, and H. Iida Essential Hydrophilic Carboxyl-terminal Regions Including Cysteine Residues of the Yeast Stretch-activated Calcium-permeable Channel Mid1 J. Biol. Chem., March 29, 2002; 277(14): 11645 - 11652. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Smith, L. Alder, J. Silk, C. Adkins, A. E. Fletcher, T. Scales, J. Kerby, G. Marshall, K. A. Wafford, R. M. McKernan, et al. Effect of alpha Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant gamma -Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux Mol. Pharmacol., April 16, 2001; 59(5): 1108 - 1118. [Abstract] [Full Text] |
||||
![]() |
G. Hapfelmeier, W. Zieglgansberger, R. Haseneder, H. Schneck, and E. Kochs Nitrous Oxide and Xenon Increase the Efficacy of GABA at Recombinant Mammalian GABAA Receptors Anesth. Analg., December 1, 2000; 91(6): 1542 - 1549. [Abstract] [Full Text] [PDF] |
||||